{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:53:08Z","timestamp":1769205188638,"version":"3.49.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Following the discovery of the Bacillus Calmette-Guerin (BCG) vaccine, its efficacy against <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic> was soon established, with several countries adopting universal BCG vaccination schemes for their populations. Soon, however, studies aimed to further establish the efficacy of the vaccine in different populations discovered that the vaccine has a larger effect in reducing mortality rate than could be explained by its effect on tuberculosis alone, which sparked suggestions that the BCG vaccine could have effects on other unrelated or non-mycobacterial pathogens causing diseases in humans. These effects were termed heterologous, non-specific or off-target effects and have been shown to be due to both innate and adaptive immune system responses. Experiments carried out in a bid to further understand these effects led to many more discoveries about the applicability of the BCG vaccine for the prevention, diagnosis, and treatment of certain disease conditions. As we approach the second century since the discovery of the vaccine, we believe it is timely to review these interesting applications of the BCG vaccine, such as in the prevention of diabetes, atherosclerosis, and leukemia; the diagnosis of Kawasaki disease; and the treatment of multiple sclerosis, non-muscle invading bladder cancer, and stage III melanoma. Furthermore, complications associated with the administration of the BCG vaccine to certain groups of patients, including those with severe combined immunodeficiency and HIV, have been well described in literature, and we conclude by describing the mechanisms behind these complications and discuss their implications on vaccination strategies, especially in low-resource settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/im9.0000000000000040","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T16:18:29Z","timestamp":1603297109000},"page":"144-150","source":"Crossref","is-referenced-by-count":3,"title":["Expanded Scope of Bacillus Calmette-Guerin (BCG) Vaccine Applicability in Disease Prophylaxis, Diagnostics, and Immunotherapeutics"],"prefix":"10.1097","volume":"2","author":[{"given":"Oluwafolajimi A.","family":"Adesanya","sequence":"first","affiliation":[{"name":"Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christabel I.","family":"Uche-Orji","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeshua A.","family":"Adedeji","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John I.","family":"Joshua","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeniyi A.","family":"Adesola","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chibuike J.","family":"Chukwudike","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12]]},"reference":[{"issue":"(1)","key":"R1-20230926","first-page":"53","article-title":"History of BCG vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica"},{"issue":"(12)","key":"R2-20230926","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag SJCFM","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"(8)","key":"R3-20230926","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/21645515.2019.1706930","article-title":"BCG: a vaccine with multiple faces","volume":"16","author":"Yamazaki-nakashimada","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"(12)","key":"R4-20230926","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apa.13585","article-title":"The ongoing story of the Bacille Calmette-Gu\u00e9rin (BCG) vaccination","volume":"105","author":"Boman","year":"2016","journal-title":"Acta Paediatr"},{"issue":"(13)","key":"R5-20230926","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(12)","key":"R6-20230926","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1128\/JB.182.12.3394-3399.2000","article-title":"A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927","volume":"182","author":"Behr","year":"2000","journal-title":"J Bacteriol"},{"issue":"(3)","key":"R7-20230926","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/eji.200425332","article-title":"The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses","volume":"35","author":"Korf","year":"2005","journal-title":"Eur J Immunol"},{"issue":"(2)","key":"R8-20230926","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/eji.201040719","article-title":"Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern","volume":"41","author":"Vander Beken","year":"2011","journal-title":"Eur J Immunol"},{"issue":"(2)","key":"R9-20230926","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) substrains","volume":"56","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"(6)","key":"R10-20230926","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"(7274)","key":"R11-20230926","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","article-title":"Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa","volume":"321","author":"Kristensen","year":"2000","journal-title":"Br Med J"},{"issue":"(1)","key":"R12-20230926","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12889-015-1497-8","article-title":"Child survival and BCG vaccination: a community based prospective cohort study in Uganda","volume":"15","author":"Nankabirwa","year":"2015","journal-title":"BMC Public Health"},{"issue":"(3)","key":"R13-20230926","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Gu\u00e9erin vaccination at first health center contact","volume":"31","author":"Biering-S\u2298rensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"(5)","key":"R14-20230926","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/jiy207","article-title":"Does BCG vaccination protect against nontuberculous mycobacterial infection? A systematic review and meta-analysis","volume":"218","author":"Zimmermann","year":"2018","journal-title":"J Infect Dis"},{"issue":"(6)","key":"R15-20230926","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/S0034-89101992000600001","article-title":"Prognostic factors for hospital case-fatality due to diarrhea or pneumonia: a case-control study","volume":"26","author":"Post","year":"1992","journal-title":"Rev Saude Publica"},{"issue":"(2)","key":"R16-20230926","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vaccine.2016.11.079","article-title":"Maternal BCG scar is associated with increased infant proinflammatory immune responses","volume":"35","author":"Mawa","year":"2017","journal-title":"Vaccine"},{"issue":"(1)","key":"R17-20230926","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/joim.12127","article-title":"Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis","volume":"275","author":"Ovchinnikova","year":"2014","journal-title":"J Intern Med"},{"key":"R18-20230926","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2016.05.031","article-title":"BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice","volume":"251","author":"van Dam","year":"2016","journal-title":"Atherosclerosis"},{"issue":"(1)","key":"R19-20230926","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(98)00284-6","article-title":"Immunization with bacillus Calmette-Guerin vaccine increases aortic atherosclerosis in the cholesterol-fed rabbit","volume":"143","author":"Lamb","year":"1999","journal-title":"Atherosclerosis"},{"issue":"(16)","key":"R20-20230926","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3109\/14767058.2014.973396","article-title":"Bacillus Calmette-Guer\u00edn vaccination: a novel therapeutic approach to preventing hyperoxic lung injury","volume":"28","author":"Kumral","year":"2015","journal-title":"J Matern Neonatal Med"},{"issue":"(4779)","key":"R21-20230926","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/190889a0","article-title":"Protective activity of fractions of tubercle bacilli against isologous tumours in mice","volume":"190","author":"Weiss","year":"1961","journal-title":"Nature"},{"issue":"(7674)","key":"R22-20230926","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0140-6736(70)91402-9","article-title":"Vaccination and leukemia mortality","volume":"296","author":"Davignon","year":"1970","journal-title":"Lancet"},{"issue":"(1)","key":"R23-20230926","first-page":"1","article-title":"Early vaccination protects against childhood leukemia: a systematic review and meta-analysis","volume":"7","author":"Morra","year":"2017","journal-title":"Sci Rep"},{"issue":"(9)","key":"R24-20230926","doi-asserted-by":"crossref","first-page":"e1912014","DOI":"10.1001\/jamanetworkopen.2019.12014","article-title":"Association of BCG vaccination in childhood with subsequent cancer diagnoses: a 60-year follow-up of a clinical trial","volume":"2","author":"Usher","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"(1)","key":"R25-20230926","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2004.09.023","article-title":"Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients","volume":"41","author":"K\u00f6lmel","year":"2005","journal-title":"Eur J Cancer"},{"issue":"(11)","key":"R26-20230926","first-page":"711","article-title":"Repeated BCG vaccination is more effective than a single dose in preventing diabetes in non-obese diabetic (NOD) mice","volume":"33","author":"Shehadeh","year":"1997","journal-title":"Isr J Med Sci"},{"issue":"(5)","key":"R27-20230926","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2337\/diacare.20.5.767","article-title":"Bacille Calmette-Guerin vaccination and incidence of IDDM in Montreal, Canada","volume":"20","author":"Parent","year":"1997","journal-title":"Diabetes Care"},{"issue":"(5)","key":"R28-20230926","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/diacare.28.5.1204","article-title":"Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes","volume":"28","author":"Huppmann","year":"2005","journal-title":"Diabetes Care"},{"key":"R29-20230926","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mehy.2019.01.007","article-title":"Can immunization with Bacillus Calmette-Gu\u00e9rin (BCG) protect against Alzheimer's disease?","volume":"123","author":"Gofrit","year":"2019","journal-title":"Med Hypotheses"},{"key":"R30-20230926","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2017.02.001","article-title":"Immunization with Bacillus Calmette-Gu\u00e9rin (BCG) alleviates neuroinflammation and cognitive deficits in APP\/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain","volume":"101","author":"Zuo","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R31-20230926","first-page":"657","article-title":"Two cases with acute febrile mucocutaneous lymph node syndrome possibly induced by vaccinia or measles vaccination","volume":"23","author":"Kawasaki","year":"1970","journal-title":"Jpn J Pediatr"},{"issue":"(4)","key":"R32-20230926","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1620\/tjem.228.351","article-title":"Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki disease","volume":"228","author":"Kakisaka","year":"2012","journal-title":"Tohoku J Exp Med"},{"issue":"(1)","key":"R33-20230926","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12887-019-1635-z","article-title":"Measles infection causing Bacillus Calmette-Gu\u00e9rin reactivation: a case report","volume":"19","author":"Muthuvelu","year":"2019","journal-title":"BMC Pediatr"},{"issue":"(5)","key":"R34-20230926","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/INF.0b013e3181cacede","article-title":"Kawasaki disease patients with redness or crust formation at the bacille calmette-gu\u00e9rin inoculation site","volume":"29","author":"Uehara","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"(10)","key":"R35-20230926","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/INF.0000000000001633","article-title":"Reaction of the BCG scar in the acute phase of Kawasaki disease in Mexican children","volume":"36","author":"Garrido-Garc\u00eda","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"(4)","key":"R36-20230926","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1177\/0300060518760462","article-title":"Analysis of factors associated with development of Bacille Calmette\u2013Gu\u00e9rin inoculation site change in patients with Kawasaki disease","volume":"46","author":"Araki","year":"2018","journal-title":"J Int Med Res"},{"issue":"(9)","key":"R37-20230926","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/1346-8138.13315","article-title":"Bull's eye dermatoscopy pattern at bacillus Calmette\u2013Gu\u00e9rin inoculation site correlates with systemic involvements in patients with Kawasaki disease","volume":"43","author":"Tseng","year":"2016","journal-title":"J Dermatol"},{"issue":"(2)","key":"R38-20230926","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0022-3476(06)80113-7","article-title":"Immunopathology and cytokine detection in the skin lesions of patients with kawasaki disease","volume":"122","author":"Sato","year":"1993","journal-title":"J Pediatr"},{"issue":"(7)","key":"R39-20230926","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03401796","article-title":"T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease","volume":"6","author":"Sireci","year":"2000","journal-title":"Mol Med"},{"issue":"(4 I)","key":"R40-20230926","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1203\/00006450-199704000-00017","article-title":"Tuberculin skin test reactivity in Kawasaki disease","volume":"41","author":"Bertotto","year":"1997","journal-title":"Pediatr Res"},{"issue":"(1)","key":"R41-20230926","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00006454-200101000-00018","article-title":"Purified protein derivative anergy in Kawasaki disease","volume":"20","author":"Kollmann","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"(2)","key":"R42-20230926","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"issue":"(922)","key":"R43-20230926","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/pmj.78.922.449","article-title":"Use of bacille Calmette-Gu\u00e9rin in superficial bladder cancer","volume":"78","author":"Meyer","year":"2002","journal-title":"Postgr Med J"},{"issue":"(9165)","key":"R44-20230926","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"issue":"(3)","key":"R45-20230926","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer-a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"(1)","key":"R46-20230926","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00941903","article-title":"Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer","volume":"25","author":"De Boer","year":"1997","journal-title":"Urol Res"},{"issue":"(5)","key":"R47-20230926","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00296835","article-title":"Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG)","volume":"21","author":"de Reijke","year":"1993","journal-title":"Urol Res"},{"issue":"(2)","key":"R48-20230926","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1878-0261.12397","article-title":"BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling","volume":"13","author":"Ibarra","year":"2019","journal-title":"Mol Oncol"},{"key":"R49-20230926","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fonc.2017.00061","article-title":"Insights into local tumor microenvironment immune factors associated with regression of cutaneous melanoma metastases by Mycobacterium bovis Bacille Calmette-Gu\u00e9rin","volume":"7","author":"Yang","year":"2017","journal-title":"Front Oncol"},{"issue":"(5296)","key":"R50-20230926","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.275.5296.77","article-title":"The inverse association between tuberculin responses and atopic disorder","volume":"275","author":"Shirakawa","year":"1997","journal-title":"Science"},{"issue":"(6)","key":"R51-20230926","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1081-1206(10)61890-X","article-title":"Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial","volume":"88","author":"Choi","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"(2)","key":"R52-20230926","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3892\/mmr.2016.5425","article-title":"Neonatal Bacillus Calmette-Gu\u00e9rin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice","volume":"14","author":"Yang","year":"2016","journal-title":"Mol Med Rep"},{"issue":"(10)","key":"R53-20230926","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jnr.23253","article-title":"Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"91","author":"La\u0107an","year":"2013","journal-title":"J Neurosci Res"},{"issue":"(9)","key":"R54-20230926","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.4049\/jimmunol.181.9.6201","article-title":"Mycobacterium bovis Bacille Calmette-Gu\u00e9rin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-\u03b3-independent manner","volume":"181","author":"Lee","year":"2008","journal-title":"J Immunol"},{"issue":"(7)","key":"R55-20230926","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of Bacille Calmette-Guerin (BCG) in multiple sclerosis","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology"},{"issue":"(2)","key":"R56-20230926","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00415-003-0967-6","article-title":"The effect of Bacille Calmette-Gu\u00e9rin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS","volume":"250","author":"Paolillo","year":"2003","journal-title":"J Neurol"},{"issue":"(11)","key":"R57-20230926","doi-asserted-by":"crossref","first-page":"e0224433","DOI":"10.1371\/journal.pone.0224433","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients","volume":"14","author":"Gofrit","year":"2019","journal-title":"PLoS One"},{"issue":"(8)","key":"R58-20230926","doi-asserted-by":"crossref","first-page":"e41756","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS One"},{"issue":"(10)","key":"R59-20230926","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41585-018-0075-0","article-title":"BCG enriches Treg cells","volume":"15","author":"Fenner","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"(12)","key":"R60-20230926","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.tem.2018.10.001","article-title":"Firing up glycolysis: BCG vaccination effects on type 1 diabetes mellitus","volume":"29","author":"Stienstra","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"(1)","key":"R61-20230926","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"(5)","key":"R62-20230926","first-page":"101085","article-title":"BCG vaccinations upregulate Myc, a central switch for improved glucose metabolism in diabetes. iScience","volume":"23","author":"K\u00fchtreiber","year":"2020"},{"issue":"(41)","key":"R63-20230926","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1016\/j.vaccine.2020.07.066","article-title":"Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone","volume":"38","author":"Klein","year":"2020","journal-title":"Vaccine"},{"issue":"(120)","key":"R66-20230926","article-title":"Further evidence of a possible correlation between the severity of COVID-19 and BCG immunization","volume":"6","author":"Dolgikh","year":"2020","journal-title":"J Infect Dis Epidemiol"},{"key":"R69-20230926","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13507","article-title":"Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination","author":"Aksu","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"(6284)","key":"R70-20230926","first-page":"427","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"(1)","key":"R71-20230926","doi-asserted-by":"crossref","first-page":"e1005271","DOI":"10.1371\/journal.ppat.1005271","article-title":"Tuberculosis in newborns: the lessons of the \u201cL\u00fcbeck Disaster\u201d (1929-1933)","volume":"12","author":"Fox","year":"2016","journal-title":"PLoS Pathog"},{"key":"R72-20230926","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/499959","article-title":"Routine childhood Bacille Calmette Guerin immunization and HIV infection","volume":"42","author":"Fordham von Reyn","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"(4)","key":"R73-20230926","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","article-title":"Bacille Calmette-Gu\u00e9rin vaccine-induced disease in HIV-infected and HIV-unifected children","volume":"42","author":"Hesseling","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"(1)","key":"R74-20230926","first-page":"e00509","article-title":"Trained immunity and susceptibility to HIV","volume":"24","author":"Derrick","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"(7)","key":"R75-20230926","doi-asserted-by":"crossref","first-page":"e41093","DOI":"10.1371\/journal.pone.0041093","article-title":"Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway","volume":"7","author":"Thayil","year":"2012","journal-title":"PLoS One"},{"issue":"(7)","key":"R76-20230926","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/433177","article-title":"Immune reconstitution syndrome due to bacillus Calmette-Gu\u00e9rin after initiation of antiretroviral therapy in children with HIV infection","volume":"41","author":"Puthanakit","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"(4)","key":"R77-20230926","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"(1)","key":"R78-20230926","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaci.2007.04.034","article-title":"BCG-osis and tuberculosis in a child with chronic granulomatous disease","volume":"120","author":"Bustamante","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"(5)","key":"R79-20230926","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pedneo.2013.04.001","article-title":"Successful unrelated cord blood stem cell transplantation in an X-linked chronic granulomatous disease patient with disseminated BCG-induced infection","volume":"56","author":"Lin","year":"2015","journal-title":"Pediatr Neonatol"},{"issue":"(4)","key":"R80-20230926","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1542\/peds.98.4.774","article-title":"Idiopathic disseminated Bacillus Calmette-Gu\u00e9rin infection: a French national retrospective study","volume":"98","author":"Casanova","year":"1996","journal-title":"Pediatrics"},{"issue":"(4)","key":"R81-20230926","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imcb.12210","article-title":"Mendelian susceptibility to mycobacterial disease: 2014-2018 update","volume":"97","author":"Rosain","year":"2019","journal-title":"Immunol Cell Biol"},{"issue":"(6)","key":"R82-20230926","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00296-005-0059-2","article-title":"Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review","volume":"26","author":"Tinazzi","year":"2006","journal-title":"Rheumatol Int"},{"issue":"(2)","key":"R83-20230926","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.asjsur.2014.01.016","article-title":"Reiter's syndrome postintravesical Bacillus Calmette\u2013Gu\u00e9rin instillations","volume":"40","author":"Ng","year":"2017","journal-title":"Asian J Surg"},{"issue":"(15)","key":"R84-20230926","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.82.15.5117","article-title":"Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans","volume":"82","author":"van Eden","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(8)","key":"R85-20230926","first-page":"e005164","article-title":"Guillain Barr\u00e9 syndrome associated with bladder instillation of Bacille Calmette Gu\u00e9rin (BCG)","volume":"5","author":"Webb","year":"2018","journal-title":"JMM Case Rep"},{"issue":"(2)","key":"R86-20230926","first-page":"127","article-title":"Anaphylactoid purpura after intravesical therapy using bacillus Calmette-Guerin for superficial bladder cancer. Article in Japanese","volume":"54","author":"Hirayama","year":"2008","journal-title":"Acta Urol Jpn"},{"issue":"(5)","key":"R87-20230926","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2169\/internalmedicine.56.7494","article-title":"Henoch Sch\u00f6nlein Purpura nephritis associated with intravesical bacillus calmette-guerin (BCG) therapy","volume":"56","author":"Tsukada","year":"2017","journal-title":"Intern Med"},{"issue":"(8)","key":"R88-20230926","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00365540510035300","article-title":"Henoch-Sch\u00f6nlein purpura after intravesical administration of bacillus Calmette-Gu\u00e9rin","volume":"37","author":"Nan","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"(8)","key":"R89-20230926","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-018-4136-9","article-title":"The first case of bacillus Calmette-Gu\u00e9rin-induced small-vessel central nervous system vasculitis","volume":"37","author":"Parent","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"(3)","key":"R90-20230926","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/jaut.2000.0494","article-title":"BCG and autoimmunity: another two-edged sword","volume":"16","author":"Shoenfeld","year":"2001","journal-title":"J Autoimmun"},{"issue":"(4)","key":"R91-20230926","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3928\/01913913-20080701-15","article-title":"Chronic anterior uveitis following bacille Calmette-Gu\u00e9rin vaccination: molecular mimicry in action?","volume":"45","author":"Spratt","year":"2008","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"(5)","key":"R92-20230926","first-page":"771","article-title":"Uveitis and vitiligo associated with BCG treatment for malignant melanoma","volume":"76","author":"Donaldson","year":"1976","journal-title":"Surgery"}],"container-title":["Infectious Microbes and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IM9.0000000000000040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T10:22:46Z","timestamp":1695723766000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IM9.0000000000000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":88,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/im9.0000000000000040","relation":{},"ISSN":["2641-5917"],"issn-type":[{"value":"2641-5917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]}}}